{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:27:27Z","timestamp":1778567247676,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.urology.2013.01.012","type":"journal-article","created":{"date-parts":[[2013,2,24]],"date-time":"2013-02-24T20:45:24Z","timestamp":1361738724000},"page":"920.e1-920.e5","source":"Crossref","is-referenced-by-count":7,"title":["Fesoterodine, Its Active Metabolite, and Tolterodine Bind Selectively to Muscarinic Receptors in Human Bladder Mucosa and Detrusor Muscle"],"prefix":"10.1016","volume":"81","author":[{"given":"Akira","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Fuchihata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiori","family":"Kuraoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayaka","family":"Osano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichiro","family":"Ozono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Masuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Araki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shizuo","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2013.01.012_bib1","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1464-410X.2006.06258.x","article-title":"Antimuscarinic drugs in detrusor overactivity and the overactive bladder syndrome: motor or sensory actions?","volume":"98","author":"Finney","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2013.01.012_bib2","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1517\/13543784.16.7.999","article-title":"Overactive bladder treatments in early phase clinical trials","volume":"16","author":"Colli","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.urology.2013.01.012_bib3","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2165\/00003495-198835040-00006","article-title":"Current concepts in the treatment of disorders of micturition","volume":"35","author":"Andersson","year":"1988","journal-title":"Drugs"},{"key":"10.1016\/j.urology.2013.01.012_bib4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0090-4295(99)00492-6","article-title":"Muscarinic receptor antagonists in the treatment of overactive bladder","volume":"55","author":"Chapple","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.urology.2013.01.012_bib5","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1517\/14656566.9.10.1787","article-title":"Fesoterodine: a novel muscarinic receptor antagonist for the treatment of overactive bladder syndrome","volume":"9","author":"Michel","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.urology.2013.01.012_bib6","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1016\/S0024-3205(01)01051-7","article-title":"Clinical experiences with tolterodine","volume":"68","author":"Nilvebrant","year":"2001","journal-title":"Life Sci"},{"key":"10.1016\/j.urology.2013.01.012_bib7","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.2174\/092986709789712835","article-title":"The design and development of fesoterodine as a prodrug of 5-hydroxymethyl tolterodine (5-HMT), the active metabolite of tolterodine","volume":"16","author":"Malhotra","year":"2009","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.urology.2013.01.012_bib8","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/j.1464-410X.2007.07358.x","article-title":"Pharmacological characterization of a novel investigational antimuscarinic drug, fesoterodine, in\u00a0vitro and in\u00a0vivo","volume":"101","author":"Ney","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2013.01.012_bib9","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1124\/jpet.108.145508","article-title":"Comparison of receptor binding characteristics of commonly used muscarinic antagonists in human bladder detrusor and mucosa","volume":"328","author":"Mansfield","year":"2009","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.urology.2013.01.012_bib10","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00210-008-0274-y","article-title":"Expression and functional role of beta-adrenoceptors in the human urinary bladder urothelium","volume":"377","author":"Otsuka","year":"2008","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.urology.2013.01.012_bib11","doi-asserted-by":"crossref","first-page":"721.e7","DOI":"10.1016\/j.urology.2011.05.011","article-title":"Characterization of muscarinic receptors in the human bladder mucosa: direct quantification of subtypes using 4-DAMP mustard","volume":"78","author":"Yoshida","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.urology.2013.01.012_bib12","first-page":"365","article-title":"Human muscarinic receptor binding characteristics of antimuscarinic agents to treat overactive bladder","volume":"175","author":"Maruyama","year":"2006","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2013.01.012_bib13","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/sj.bjp.0706147","article-title":"Muscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT-PCR: changes in ageing","volume":"144","author":"Mansfield","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.urology.2013.01.012_bib14","doi-asserted-by":"crossref","first-page":"869","DOI":"10.2147\/TCRM.S6483","article-title":"Fesoterodine for the treatment of urinary incontinence and overactive bladder","volume":"5","author":"Ellsworth","year":"2009","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.urology.2013.01.012_bib15","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1742-1241.2010.02361.x","article-title":"Long-term safety, tolerability and efficacy of fesoterodine treatment in subjects with overactive bladder symptoms","volume":"64","author":"Van Kerrebroeck","year":"2010","journal-title":"Clin Pract"},{"key":"10.1016\/j.urology.2013.01.012_bib16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1757-5672.2011.00091.x","article-title":"Efficacy, safety and tolerability of fesoterodine in Asian patients with overactive bladder","volume":"3","author":"Yamaguchi","year":"2011","journal-title":"LUTS"},{"key":"10.1016\/j.urology.2013.01.012_bib17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1124\/jpet.110.172288","article-title":"Selective binding of bladder muscarinic receptors in relation to the pharmacokinetics of a novel antimuscarinic agent, imidafenacin, to treat overactive bladder","volume":"336","author":"Yamada","year":"2011","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.urology.2013.01.012_bib18","first-page":"1892","article-title":"Intravesical oxybutynin: a local anesthetic effect on bladder C afferents","volume":"169","author":"De Wachter","year":"2003","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2013.01.012_bib19","first-page":"2032","article-title":"Effects of tolterodine on an overactive bladder depend on suppression of C-fiber bladder afferent activity in rats","volume":"174","author":"Yokoyama","year":"2005","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.urology.2013.01.012_bib20","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.eururo.2007.02.057","article-title":"Effects of the M3 receptor selective muscarinic antagonist darifenacin on bladder afferent activity of the rat pelvic nerve","volume":"52","author":"Iijima","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2013.01.012_bib21","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/nau.20208","article-title":"Systemic oxybutynin decreases afferent activity of the pelvic nerve of the rat: new insights into the working mechanism of antimuscarinics","volume":"25","author":"De Laet","year":"2006","journal-title":"Neurourol Urodyn"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429513000368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429513000368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T10:48:07Z","timestamp":1644403687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429513000368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0090429513000368"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2013.01.012","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}